Patients with heart block see strong benefit from cardiac resynchronization therapy

November 6, 2012

Heart failure patients with a condition called "heart block" derive significant benefit from cardiac resynchronization therapy (CRT), according to the results of the Block HF clinical trial, presented today at the American Heart Association Scientific Sessions 2012 meeting in Los Angeles.

Anne B. Curtis, MD, Charles and Mary Bauer Professor and Chair of Medicine in the University at Buffalo School of Medicine and Biomedical Sciences and principal investigator of Block HF, presented results of the eight-year-long, national, multicenter, randomized clinical trial sponsored by , Inc., which enrolled more than 900 patients. Curtis discusses the results in this video:

"These findings confirm what some clinicians and researchers have hypothesized for some time—that with block do better when both sides of the heart are resynchronized, called biventricular pacing, using a cardiac resynchronization therapy (CRT) device," she says. "The results of Block HF may lead to a reassessment of treatment guidelines for patients with heart block."

In the trial, 349 patients underwent biventricular pacing with a CRT device and 342 patients underwent the conventional right ventricular pacing. Patients who underwent biventricular pacing had a 26 percent reduction in the combined endpoint of mortality, heart-failure related urgent care and deterioration in detected by .

There also was a 27 percent relative risk reduction in the composite endpoint of heart failure urgent care and all-cause mortality.

The Block HF trial was designed to address the best way to treat atrioventricular block (AV block), a partial or complete block in the main "trunk" of the heart's electrical conduction system.

"AV block prevents from reaching the bottom chambers of the heart, which then beat very slowly or not at all," explains Curtis.

To treat AV block, many patients are implanted with a standard pacemaker with leads or pacing wires in the top chamber (right atrium) and the bottom chamber (right ventricle) of the heart. "But that fix can lead to other problems," Curtis says, "such as creating less synchrony between the left and right ventricles of the heart, making their heart failure symptoms even worse."

Researchers and clinicians have hypothesized that better outcomes might result from pacing both the left and right ventricles of the heart, called biventricular pacing, which involves implanting a device.

"Implanting these devices is more complicated than putting in a standard pacemaker, something clinicians don't want to put through without clear evidence of a benefit," says Curtis. "Today, we are announcing that Block HF does show that benefit."

Heart failure affects approximately 6 million people in the U.S. at a cost of somewhere between $20 and 56 billion/year. Of those, AV block affects more than 800,000 Americans and more than a million people worldwide.

Curtis, a UB faculty member since 2010, is one of the world's leading clinical cardiac electrophysiologists and an expert in cardiac arrhythmias. Her clinical research has significantly advanced knowledge of human cardiac electrophysiology and heart rhythm abnormalities.

Her research interests include clinical trials in implantable device therapy for prevention of sudden cardiac death and management of heart failure, as well as clinical trials in atrial fibrillation. She has been principal investigator, co-investigator, sponsor or steering committee member on 85 research studies and clinical trials and she has written more than 250 peer-reviewed manuscripts, book chapters, reviews and editorials. She also is author of a book on cardiac pacing.

Explore further: Chronic right ventricular pacing works for ICD patients with left ventricular dysfunction

Related Stories

Chronic right ventricular pacing works for ICD patients with left ventricular dysfunction

March 26, 2012
Cardiac resynchronization therapy with defibrillators (CRT-D) is appropriate for patients who have left ventricular dysfunction and require chronic ventricular pacing, based on the findings of an observational study that ...

HFSA updates recommendations for use of cardiac resynchronization therapy

February 27, 2012
Based on a review of the latest evidence, the Guidelines Committee of the Heart Failure Society of America now recommends that the use of cardiac resynchronization therapy (CRT) be expanded to a larger group of patients with ...

Recommended for you

New molecule may hold the key to triggering the regeneration and repair of damaged heart cells

August 21, 2017
New research has discovered a potential means to trigger damaged heart cells to self-heal. The discovery could lead to groundbreaking forms of treatment for heart diseases. For the first time, researchers have identified ...

Researchers investigate the potential of spider silk protein for engineering artificial heart

August 18, 2017
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac ...

Lasers used to detect risk of heart attack and stroke

August 18, 2017
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light to identify high-risk arterial plaques, according to research carried out at WMG, University of ...

Cholesterol crystals are sure sign a heart attack may loom

August 17, 2017
A new Michigan State University study on 240 emergency room patients shows just how much of a role a person's cholesterol plays, when in a crystallized state, during a heart attack.

How Gata4 helps mend a broken heart

August 15, 2017
During a heart attack, blood stops flowing into the heart; starved for oxygen, part of the heart muscle dies. The heart muscle does not regenerate; instead it replaces dead tissue with scars made of cells called fibroblasts ...

Injectable tissue patch could help repair damaged organs

August 14, 2017
A team of U of T Engineering researchers is mending broken hearts with an expanding tissue bandage a little smaller than a postage stamp.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.